| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/jcamd/TanMCLPSY13 |
| P6179 | Dimensions Publication ID | 1051133467 |
| P356 | DOI | 10.1007/S10822-013-9697-8 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s10822-013-9697-8 |
| P698 | PubMed publication ID | 24322389 |
| P2093 | author name string | Li Yang | |
| Hu Mei | |||
| Wen Tan | |||
| Mao Shu | |||
| Tengfei Liu | |||
| Li Chao | |||
| Xianchao Pan | |||
| P2860 | cites work | Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding | Q24657908 |
| PROCHECK: a program to check the stereochemical quality of protein structures | Q26778411 | ||
| Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine | Q28207735 | ||
| Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein | Q28477346 | ||
| Exhaustive sampling of docking poses reveals binding hypotheses for propafenone type inhibitors of P-glycoprotein | Q31011332 | ||
| Comparative evaluation of eight docking tools for docking and virtual screening accuracy | Q33206310 | ||
| Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors | Q33310540 | ||
| CyclinPred: a SVM-based method for predicting cyclin protein sequences. | Q33348569 | ||
| Molecular models of human P-glycoprotein in two different catalytic states | Q33401731 | ||
| Signal transduction pathways and transcriptional mechanisms as targets for prevention of emergence of multidrug resistance in human cancer cells | Q34314971 | ||
| The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve | Q34557148 | ||
| Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. | Q34559072 | ||
| A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields | Q34754007 | ||
| Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy | Q35915497 | ||
| What is a support vector machine? | Q36679246 | ||
| A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model. | Q37172880 | ||
| Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression | Q37849716 | ||
| Microparticles and their emerging role in cancer multidrug resistance. | Q37901204 | ||
| A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors. | Q39302228 | ||
| Molecular docking studies and in vitro screening of new dihydropyridine derivatives as human MRP1 inhibitors | Q39550936 | ||
| Multidrug resistance strength of the novel multidrug resistance gene HA117: compared with MRP1. | Q39679547 | ||
| Homology modeling and binding site assessment of the human P-glycoprotein | Q39766645 | ||
| Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors | Q42326093 | ||
| Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport | Q42461714 | ||
| Combined pharmacophore modeling, docking, and 3D QSAR studies of ABCB1 and ABCC1 transporter inhibitors | Q43273710 | ||
| Influence of glioma's multidrug resistance phenotype on (99m)Tc-tetrofosmin uptake | Q46402928 | ||
| P-glycoprotein targeted nanoscale drug carriers. | Q51017736 | ||
| Peptide binding specificities of HLA-B*5701 and B*5801. | Q51317293 | ||
| ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques. | Q51590505 | ||
| The conserved tyrosine residues 401 and 1044 in ATP sites of human P-glycoprotein are critical for ATP binding and hydrolysis: evidence for a conserved subdomain, the A-loop in the ATP-binding cassette. | Q52668947 | ||
| The flexibility of P-glycoprotein for its poly-specific drug binding from molecular dynamics simulations | Q58195302 | ||
| Comparative analysis of binding affinities between styrene and mammalian CYP2E1 by bioinformatics approaches | Q83675278 | ||
| Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin | Q84232704 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1067-1073 | |
| P577 | publication date | 2013-12-10 | |
| P1433 | published in | Journal of Computer - Aided Molecular Design | Q15766522 |
| P1476 | title | Combined QSAR and molecule docking studies on predicting P-glycoprotein inhibitors | |
| P478 | volume | 27 |
| Q38756967 | Advances in plant-based inhibitors of P-glycoprotein |
| Q64110057 | An Energetically Favorable Ligand Entrance Gate of a Multidrug Transporter Revealed by Partial Nudged Elastic Band Simulations |
| Q38715008 | Computational modeling to predict the functions and impact of drug transporters. |
| Q38902467 | Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status |
| Q38390892 | Improvements, trends, and new ideas in molecular docking: 2012-2013 in review. |
| Q57176854 | Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective |
| Q37114323 | Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer |
Search more.